Jade Biosciences, Inc. · BOATS:JBIO

Jade Biosciences, Inc. financial statements

Jade Biosciences, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue0
Cost of revenue26.0K282.0K96.0K68.0K15.0K1.00K
Gross profit-26.0K-282.0K-96.0K-68.0K-15.0K-1.00K
Research and development93.1M53.2M64.2M38.6M15.0M7.94M
Selling, general and administrative20.2M8.61K
Operating income-113.5M-74.6M-81.4M-53.2M-23.0M-8.89M
Depreciation and amortization26.0K282.0K96.0K68.0K15.0K1.00K
EBITDA-113.5M-74.3M-81.3M-53.2M-23.0M-8.89M
Interest expense75.0K
Income before tax-127.4M-69.6M-75.5M-51.5M-23.0M-9.61M
Income tax58.0K55.0K56.0K25.0K3.00K
Net income-127.4M-69.6M-75.5M-51.5M-23.0M-9.61M
Earnings per share, basic-3.19-2.44-2.87-2.10-1.87-40.31
Earnings per share, diluted-3.19-2.44-2.87-2.10-1.87-40.31

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents88.4M69.4M23.5M22.4M54.2M4.57M
Short-term investments247.7M098.9M106.8M113.2M
Current assets348.8M69.7M124.2M131.5M174.3M4.68M
Property, plant and equipment170.0K0288.0K242.0K186.0K39.0K
Total assets349.8M72.8M127.4M135.3M175.4M4.71M
Accounts payable2.15M1.29M2.40M2.58M1.21M618.0K
Current liabilities16.5M12.0M17.6M7.78M2.55M1.77M
Long-term debt107.6M
Total debt724.0K417.0K675.0K1.09M574.0K
Total liabilities17.3M119.6M18.0M8.56M2.94M1.77M
Shareholders' equity332.5M-46.8M109.5M126.7M172.4M-13.3M
Shares outstanding49.3M3.67M27.8M24.7M24.4M243.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-94.7M-71.2M-56.8M-39.1M-27.4M-7.86M
Capital spending-196.0K0-142.0K-195.0K-181.0K0
Free cash flow-94.9M-71.2M-56.9M-39.3M-27.6M-7.86M
Cash from investing-247.0M56.0M11.9M6.93M-113.4M
Cash from financing360.8M25.4M46.0M396.0K190.5M8.92M
Change in cash19.1M10.3M1.09M-31.8M49.6M1.06M